Jennison Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $752M | Buy |
6,249,337
+689,849
| +12% | +$79.6M | 0.52% | 39 |
|
|
2025
Q4 | $585M | Buy |
+5,559,488
| New | +$522M | 0.35% | 40 |
|
|
2024
Q4 | – | Sell |
-1,080,765
| Closed | -$123M | – | 619 |
|
|
2024
Q3 | $123M | Sell |
1,080,765
-728,756
| -40% | -$86.6M | 0.08% | 115 |
|
|
2024
Q2 | $224M | Buy |
1,809,521
+229,126
| +14% | +$29.5M | 0.14% | 68 |
|
|
2024
Q1 | $209M | Sell |
1,580,395
-20,623
| -1% | -$2.54M | 0.14% | 66 |
|
|
2023
Q4 | $175M | Buy |
1,601,018
+37,765
| +2% | +$3.92M | 0.13% | 74 |
|
|
2023
Q3 | $161M | Sell |
1,563,253
-55,015
| -3% | -$5.93M | 0.14% | 73 |
|
|
2023
Q2 | $187M | Buy |
1,618,268
+430,320
| +36% | +$48.9M | 0.15% | 69 |
|
|
2023
Q1 | $126M | Sell |
1,187,948
-193,606
| -14% | -$20.9M | 0.12% | 94 |
|
|
2022
Q4 | $153M | Buy |
1,381,554
+515,532
| +60% | +$52.7M | 0.16% | 90 |
|
|
2022
Q3 | $74.6M | Sell |
866,022
-773,717
| -47% | -$69.1M | 0.07% | 137 |
|
|
2022
Q2 | $149M | Buy |
1,639,739
+1,489,602
| +992% | +$132M | 0.15% | 85 |
|
|
2022
Q1 | $12.3M | Buy |
+150,137
| New | +$11.8M | 0.01% | 404 |
|
|
2020
Q4 | – | Sell |
-26,792
| Closed | -$2.12M | – | 679 |
|
|
2020
Q3 | $2.12M | Sell |
26,792
-111,569
| -81% | -$8.74M | ﹤0.01% | 482 |
|
|
2020
Q2 | $10.2M | Sell |
138,361
-566,615
| -80% | -$42.7M | 0.01% | 369 |
|
|
2020
Q1 | $51.8M | Sell |
704,976
-6,182
| -0.9% | -$486K | 0.06% | 142 |
|
|
2019
Q4 | $61.7M | Sell |
711,158
-307,020
| -30% | -$25.2M | 0.06% | 171 |
|
|
2019
Q3 | $81.8M | Sell |
1,018,178
-896,967
| -47% | -$71.9M | 0.09% | 134 |
|
|
2019
Q2 | $153M | Sell |
1,915,145
-11,537,082
| -86% | -$883M | 0.15% | 81 |
|
|
2019
Q1 | $1.07B | Sell |
13,452,227
-3,082,369
| -19% | -$231M | 1.06% | 31 |
|
|
2018
Q4 | $1.21B | Buy |
16,534,596
+12,626,730
| +323% | +$891M | 1.35% | 22 |
|
|
2018
Q3 | $265M | Buy |
3,907,866
+2,938,523
| +303% | +$187M | 0.24% | 54 |
|
|
2018
Q2 | $56.1M | Buy |
969,343
+96,289
| +11% | +$5.43M | 0.05% | 250 |
|
|
2018
Q1 | $45.4M | Sell |
873,054
-155,790
| -15% | -$8.41M | 0.05% | 269 |
|
|
2017
Q4 | $55.2M | Sell |
1,028,844
-987,891
| -49% | -$54.8M | 0.05% | 250 |
|
|
2017
Q3 | $123M | Sell |
2,016,735
-20,545
| -1% | -$1.25M | 0.13% | 123 |
|
|
2017
Q2 | $125M | Sell |
2,037,280
-237,401
| -10% | -$14.5M | 0.13% | 121 |
|
|
2017
Q1 | $138M | Sell |
2,274,681
-33,479
| -1% | -$2.03M | 0.15% | 109 |
|
|
2016
Q4 | $130M | Sell |
2,308,160
-252,192
| -10% | -$14.8M | 0.14% | 116 |
|
|
2016
Q3 | $152M | Buy |
2,560,352
+46,666
| +2% | +$2.73M | 0.16% | 101 |
|
|
2016
Q2 | $138M | Sell |
2,513,686
-54,774
| -2% | -$2.92M | 0.15% | 116 |
|
|
2016
Q1 | $130M | Sell |
2,568,460
-758,963
| -23% | -$37.2M | 0.14% | 126 |
|
|
2015
Q4 | $168M | Sell |
3,327,423
-3,311,804
| -50% | -$167M | 0.16% | 103 |
|
|
2015
Q3 | $313M | Sell |
6,639,227
-1,263,391
| -16% | -$67.1M | 0.32% | 62 |
|
|
2015
Q2 | $429M | Sell |
7,902,618
-155,444
| -2% | -$8.72M | 0.39% | 60 |
|
|
2015
Q1 | $442M | Buy |
8,058,062
+1,198,688
| +17% | +$67.9M | 0.4% | 58 |
|
|
2014
Q4 | $372M | Sell |
6,859,374
-13,743,302
| -67% | -$766M | 0.35% | 64 |
|
|
2014
Q3 | $1.17B | Sell |
20,602,676
-224,244
| -1% | -$12.6M | 1.08% | 24 |
|
|
2014
Q2 | $1.15B | Sell |
20,826,920
-3,617,182
| -15% | -$197M | 1.06% | 23 |
|
|
2014
Q1 | $1.32B | Buy |
24,444,102
+11,732,725
| +92% | +$608M | 1.27% | 11 |
|
|
2013
Q4 | $607M | Buy |
12,711,377
+9,691,237
| +321% | +$443M | 0.6% | 48 |
|
|
2013
Q3 | $137M | Sell |
3,020,140
-26,400
| -0.9% | -$1.21M | 0.14% | 143 |
|
|
2013
Q2 | $135M | Buy |
+3,046,540
| New | +$136M | 0.15% | 137 |
|
Other funds holding MRK
VCM
VPM
Jennison Associates's MRK Position: Q1 2026 in Review
Jennison Associates increased its Merck (MRK) stake by 12% in Q1 2026, buying an estimated $79.6M and bringing the position to 6,249,337 shares worth $752M. The position accounts for 0.52% of the portfolio, ranked #39.
Jennison Associates first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.32B in Q1 2014. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Jennison Associates held 6,249,337 shares of Merck worth $752M as of Q1 2026.
- Jennison Associates bought 689,849 Merck shares in Q1 2026, an estimated $79.6M.
- Merck made up 0.52% of Jennison Associates's portfolio in Q1 2026, its #39 holding.
- Jennison Associates first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
- Jennison Associates's Merck position peaked at $1.32B in Q1 2014.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.